日本の医薬品開発・製造受託機関の市場規模は、2024年に133億1000万ドルと推定され、2025年から2030年の間にCAGR 7.77%で成長すると予測されます。この成長を牽引する主な要因には、バイオ医薬品の需要の高まり、疾病負担の増加、高齢者人口の増加などがあります。さらに、医薬品開発・製造受託機関 (CDMO) による施設やサービスの拡大への投資の増加が、予測期間中に市場の成長をさらに促進すると予想されます。バイオ医薬品業界の利益率も、価格圧力の高まり、規制上の課題、特許の失効により縮小しました。受託サービスは、これらの問題の克服を支援するため、バイオ医薬品および製薬会社から「戦略的競争兵器」と見なされていました。これらのサービスは、顧客の資金を節減します。また、時間の節約にも役立ち、製造・研究施設の運営と管理に効率的に活用することができました。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Estimates and forecasts timeline.
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Bottom Up Approach (Model 2)
1.7.3. Value Chain Based Approach (Model 3)
1.7.4. Multivariate Analysis (Model 4)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Japan Contract Development and Manufacturing Organizations Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Demand for Biopharmaceutical Drugs in Japan
3.2.1.2. High Geriatric Population And Growing Disease Burden in Japan
3.2.1.3. Low Cost Associated with Outsourcing Drug Manufacturing and Development Services
3.2.2. Market Restraint Analysis
3.2.2.1. Limited Outsourcing Opted by Big Pharma Companies
3.2.2.2. Quality Issues While Outsourcing
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Business Model Analysis
3.6. Regulatory Framework
3.7. Clinical Trials Volume Analysis, 2024
3.7.1. Total Number of Clinical Trials, by Phase (2024)
3.7.2. Total Number of Clinical Trials, by Study Design (2024)
3.7.3. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
3.8. Japan Contract Development and Manufacturing Organizations Market Analysis Tools
3.8.1. Porter’s Five Forces Analysis
3.8.2. PESTEL Analysis
3.8.3. COVID-19 Impact Analysis
Chapter 4. Japan Contract Development and Manufacturing Organizations Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Japan Contract Development and Manufacturing Organizations Market: Product Movement Analysis
4.3. Japan Contract Development and Manufacturing Organizations Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. API
4.4.1. API Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Type
4.4.2.1. Traditional Active Pharmaceutical Ingredient (Traditional API)
4.4.2.1.1. Traditional Active Pharmaceutical Ingredient (Traditional API) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Highly Potent Active Pharmaceutical Ingredient (HP-API)
4.4.2.2.1. Highly Potent Active Pharmaceutical Ingredient (HP-API) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Antibody Drug Conjugate (ADC)
4.4.2.3.1. Antibody Drug Conjugate (ADC) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Others
4.4.2.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Synthesis
4.4.3.1. Synthetic
4.4.3.1.1. Synthetic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3.1.2. Solid
4.4.3.1.2.1. Solid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3.1.3. Liquid
4.4.3.1.3.1. Liquid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3.2. Biotech
4.4.3.2.1. Biotech Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Drug
4.4.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.2. Innovative
4.4.4.2.1. Innovative Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4.3. Generics
4.4.4.3.1. Generics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Manufacturing
4.4.5.1. Continuous manufacturing
4.4.5.1.1. Continuous Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5.2. Batch manufacturing
4.4.5.2.1. Batch Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Drug Product
4.5.1. By Drug Type
4.5.1.1. Oral Solid Dose
4.5.1.1.1. Oral Solid Dose Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.2. Semi-Solid Dose
4.5.1.2.1. Semi-Solid Dose Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.3. Liquid Dose
4.5.1.3.1. Liquid Dose Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.4. Others
4.5.1.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. By Type
4.5.2.1. Innovative
4.5.2.1.1. Innovative Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2.2. Generic
4.5.2.2.1. Generic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. By Molecule
4.5.3.1. Small Molecule
4.5.3.1.1. Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3.2. Large Molecule
4.5.3.2.1. Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Japan Contract Development and Manufacturing Organizations Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Japan Contract Development and Manufacturing Organizations Market: Workflow Movement Analysis
5.3. Japan Contract Development and Manufacturing Organizations Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Clinical
5.4.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Commercial
5.5.1. Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Japan Contract Development and Manufacturing Organizations Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Japan Contract Development and Manufacturing Organizations Market: Application Movement Analysis
6.3. Japan Contract Development and Manufacturing Organizations Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Hormonal
6.5.1. Hormonal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Glaucoma
6.6.1. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Cardiovascular Diseases
6.7.1. Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Diabetes
6.8.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Japan Contract Development and Manufacturing Organizations Market: Service Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Japan Contract Development and Manufacturing Organizations Market: Service Movement Analysis
7.3. Japan Contract Development and Manufacturing Organizations Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
7.4. Contract Development
7.4.1. Contract Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Contract Manufacturing
7.5.1. Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Packaging
7.6.1. Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Quality Control and Assurance
7.7.1. Quality Control and Assurance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Visual Inspection
7.7.2.1. Visual Inspection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Others
7.7.3.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Japan Contract Development and Manufacturing Organizations Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Japan Contract Development and Manufacturing Organizations Market: End Use Movement Analysis
8.3. Japan Contract Development and Manufacturing Organizations Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Pharmaceutical Companies
8.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Biotechnology Companies
8.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Japan Contract Development and Manufacturing Organizations Market: Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Company Market Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. LabCorp
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Wuxi AppTec, Inc.
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Lonza
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Recipharm AB
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Samsung Biologics
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Catalent, Inc.
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. CordenPharma International
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Cambrex Corporation
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific, Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. FUJIFILM Diosynth Biotechnologies
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Sumitomo Chemical Company, Limited
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Service Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. CMIC HOLDINGS Co., LTD.
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Service Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Bushu Pharmaceuticals Ltd.
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Service Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Nipro Corporation
9.3.14.1. Company Overview
9.3.14.2. Financial Performance
9.3.14.3. Service Benchmarking
9.3.14.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Japan Contract Development and Manufacturing Organizations Market, By Product, 2018 - 2030 (USD Million)
Table 4 Japan Contract Development and Manufacturing Organizations Market, By Workflow, 2018 - 2030 (USD Million)
Table 5 Japan Contract Development and Manufacturing Organizations Market, By Application, 2018 - 2030 (USD Million)
Table 6 Japan Contract Development and Manufacturing Organizations Market, Service, 2018 - 2030 (USD Million)
Table 7 Japan Contract Development and Manufacturing Organizations Market, By End Use, 2018 - 2030 (USD Million)
Table 8 ADC Approvals in Japan
Table 9 Financial Performance
Table 10 Key company initiating service launches/upgrades
Table 11 Key companies initiating service launches/upgrades
Table 12 Key companies initiating partnerships
Table 13 Key companies initiating expansion
Table 14 Key companies initiating expansion
List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market Research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Japan contract development and manufacturing organizations market segmentation
Fig. 7 Market driver analysis
Fig. 8 Market restraint relevance analysis
Fig. 9 Porter’s five forces analysis
Fig. 10 PESTEL by SWOT analysis
Fig. 11 Regional marketplace: Key takeaways
Fig. 12 Japan synthetic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 Japan solid market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Japan liquid market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Japan biotech market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Japan Traditional Active Pharmaceutical Ingredient (Traditional API) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Japan Highly Potent Active Pharmaceutical Ingredient (HP-API) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Japan Antibody Drug Conjugate (ADC) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Japan innovative market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Japan generics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Japan continuous manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Japan batch manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Japan oral solid dose market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Japan semi-solid dose market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Japan liquid dose market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Japan innovative market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Japan generics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Japan small molecule market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Japan large molecule market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Japan clinical market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Japan commercial market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Japan oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Japan hormonal market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Japan glaucoma market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Japan cardiovascular disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Japan diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Japan contract development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Japan contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Japan packaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan quality control and assurance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Japan visual inspection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Japan biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan others market estimates and forecasts, 2018 - 2030 (USD Million)
